Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood.2024027114 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intrasalivary Thymic Carcinoma: A Case Report and Literature Review.
Head Neck Pathol
September 2022
Department of Pathomorphology, Medical University of Gdansk, Smoluchowskiego 17, Gdańsk, Poland.
Ectopic thymic carcinomas are rarely diagnosed in the thyroid gland, let alone in extrathyroid tissues. In the currently available literature, only five cases of extrathyroidal malignancies with thymic differentiation have been reported as arising in the major salivary glands. A 69-year-old female presented with a slow-growing palpable mass in the left parotid gland.
View Article and Find Full Text PDFAggressive B-cell lymphomas with a primary bone marrow presentation.
Histopathology
September 2020
Institute of Pathology and Comprehensive Cancer Centre, Tübingen University Hospital, Tübingen, Germany.
Aggressive B-cell lymphomas present as a heterogeneous spectrum of disease. A primary diagnosis in the bone marrow (BM) may be challenging in terms of diagnostic classification and clinical handling, owing to limited architectural information. Aggressive B-cell lymphomas can be subdivided into entities that typically present primarily in the BM, and cases with BM involvement in which the bulk of disease is present in other organs.
View Article and Find Full Text PDFIntrathyroid epithelial thymoma (ITET) and carcinoma showing thymus-like differentiation (CASTLE): CD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid.
Histol Histopathol
May 2013
Department of Medical Technology, Kobe-Tokiwa University, Kobe 653-0838, Japan.
Carcinoma of possible thymic epithelial origin may occur within the thyroid gland, which was first reported by Miyauchi et al. as intrathyroid epithelial thymoma (ITET). ITET is a rare tumor comprising about 0.
View Article and Find Full Text PDFCD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
Cytometry B Clin Cytom
December 2010
Division of Hematology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Background: The pathology and clinical course of patients with CD5+ chronic B-cell lymphoproliferative disorders, excluding those that present with typical chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) or mantle cell lymphoma, (i.e. CD5+B-CLPD) are poorly defined.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!